Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of RHB-104 in moderately to severely active Crohn's disease
2015-001179-36Phase 3Completed
- Sponsor
- RedHill Biopharma
- Start
- Jun 2015
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing RHB-104 with Placebo (2 arms). Primary endpoint: Remission. Started Jun 2015; status: completed.
02
Drugs
RHB-104
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2015-001179-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001179-36.